Correction to: Benefit for single-agent adjuvant chemotherapy in elderly patients with locally advanced gastric adenocarcinoma

被引：0

作者：

Ofer Margalit

Shun Yu

Einat Shacham-Shmueli

Gal Strauss

Yu-Xiao Yang

Yaacov R. Lawrence

Kim A. Reiss

Talia Golan

Naama Halpern

Dan Aderka

Bruce Giantonio

Ronac Mamtani

Ben Boursi

机构：

[1] Sheba Medical Center,Institute of Oncology

[2] Tel-Aviv University,Center for Clinical Epidemiology and Biostatistics

[3] Perelman School of Medicine at the University of Pennsylvania,Abramson Cancer Center

[4] University of Pennsylvania,Division of Gastroenterology, Department of Medicine

[5] Perelman School of Medicine at the University of Pennsylvania,Department of Radiation Oncology

[6] Sidney Kimmel Medical College at Thomas Jefferson University,Division of Hematology and Oncology, Department of Medicine

[7] Massachusetts General Hospital,undefined

[8] Harvard Medical School,undefined

来源：

Journal of Cancer Research and Clinical Oncology | 2022年 / 148卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1709 / 1709

共 50 条

[41] Combination or single-agent chemotherapy as adjuvant treatment of gastric cancer A systematic review and meta-analysis of published trials
Iacovelli, Roberto
Pietrantonio, Filippo
Maggi, Claudia
de Braud, Filippo
Di Bartolomeo, Maria
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 98 : 24 - 28
[42] Single-agent chemotherapy for the treatment of elderly patients with advanced non-small-cell lung cancer: What is the best drug? Reply
Kudoh, Shinzoh
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (11) : 1446 - 1446
[43] Fatigue in patients with locally advanced or metastatic breast cancer undergoing single-agent taxane-based chemotherapy: de novo versus relapsed
Blaes, Anne
Gavioli, Elizabeth M.
Wakade, Renuka
Miracle, Santiago
DiTuri, Giovanna
DePizzol, Maria
Ruffini, Pier Adelchi
Sergio, Francesco
Leone, Manuela
Mantelli, Flavio
Allegretti, Marcello
Fabi, Alessandra
CANCER RESEARCH, 2023, 83 (05)
[44] COMPARISON OF SINGLE-AGENT EPIRUBICIN AND 5-FLUOROURACIL EPIRUBICIN MITOMYCIN IN PATIENTS WITH ADVANCED ADENOCARCINOMA OF THE PANCREAS
TOPHAM, C
GLEES, J
COOMBES, RC
ONCOLOGY, 1993, 50 : 78 - 83
[45] Phase II single-agent studies in elderly cancer patients
Monfardini, S
Lonardi, S
TUMORI, 2002, 88 (01) : S13 - S14
[46] Safety of First-line Chemotherapy with Metronomic Single-agent Oral Vinorelbine in Elderly Patients with NSCLC
Mencoboni, Manlio
Filiberti, Rosa Angela
Taveggia, Paola
Del Corso, Lisette
Del Conte, Alessandro
Covesnon, Maria Grazia
Puccetti, Cheti
Donati, Sara
Auriati, Laura
Amoroso, Domenico
Camerini, Andrea
ANTICANCER RESEARCH, 2017, 37 (06) : 3189 - 3194
[47] The Correlation of Efficacy with Cycles of Adjuvant Chemotherapy for Resected Locally Advanced Gastric Cancer
Li, G.
Zhang, Z.
Ma, X.
Zhu, J.
Cai, G.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S331 - S331
[48] Adjuvant Chemotherapy Use in Patients With Locally Advanced Rectal Cancer: A Single-Institution Experience
Li, Franklin
Nielsen, Gradon
Baran, Andrea
Hu, John
Wallace, Danielle
Preslar, Matthew
Fleming, Fergal
Temple, Larissa
Dunne, Richard F.
Noel, Marcus
Hezel, Aram F.
Tejani, Mohamedtaki A.
CLINICAL COLORECTAL CANCER, 2020, 19 (03) : E124 - E128
[49] Survival Benefit of Perioperative Chemotherapy in Patients with Locally Advanced Gastric Cancer: a Propensity Score Matched Analysis
Eom, Bang Wool
Kim, Sohee
Kim, Ja Yeon
Yoon, Hong Man
Kim, Mi-Jung
Nam, Byung-Ho
Kim, Young-Woo
Park, Young-lee
Park, Sook Ryun
Ryu, Keun Won
JOURNAL OF GASTRIC CANCER, 2018, 18 (01) : 69 - 81
[50] Erlotinib as a single-agent therapy in patients with advanced pancreatic cancer
Epelbaum, Ron
Schnaider, Julia
Gluzman, Alexander
Figer, Arie
ANNALS OF ONCOLOGY, 2006, 17 : 322 - 322

← 1 2 3 4 5 →